CTNNB1 and hepatocellular carcinoma: The proportion of low-risk patients with CTNNB1-mutant HCC was significantly higher than that of patients with wild-type CTNNB-1 (74.7% vs. 53.0%, p < 0.001, Supplementary Figure 1B).